Characterization of proton-activated implantable markers for proton range verification using PET J. Cho1, G. Ibbott1, M. Kerr1, R. A. Amos2, F. Stingo1,

Slides:



Advertisements
Similar presentations
1 Low-Dose Dual-Energy CT for PET Attenuation Correction with Statistical Sinogram Restoration Joonki Noh, Jeffrey A. Fessler EECS Department, The University.
Advertisements

Introduction Radiostereometry (RSA) is well established research method for assessing movement of orthopaedic implants, bone fractures, and.
Esteban Fabián Boggio 1 Lucas Provenzano 2 Sara Gonzalez 2,3 Sara Gonzalez 2,3 Juan Manuel Longhino 1 1 Bariloche Atomic Center, Atomic Energy National.
Alexander Klyachko, IU Cyclotron, PTCOG51, Seoul, South Korea, May 17-19, 2012 A.V. Klyachko 1, D.F. Nichiporov 1, L. Coutinho 2, C.-W. Cheng 2, 3, M.
Evaluation of the characteristics of TLD LiF:Mg.Ti-100 Powder: A Measure of Consistency Between Multiple Batches of Powder Paola Alvarez,Jose Francisco.
University of Florida, Jacksonville, FL
Tumour Therapy with Particle Beams Claus Grupen University of Siegen, Germany [physics/ ] Phy 224B Chapter 20: Applications of Nuclear Physics 24.
Interactions of charged particles with the patient I.The depth-dose distribution - How the Bragg Peak comes about - (Thomas Bortfeld) II.The lateral dose.
An algorithm for metal streaking artifact reduction in cone beam CT M. Bazalova 1,2, G. Landry 1, L. Beaulieu 3, F. Verhaegen 1,4 1-McGill University,
tomos = slice, graphein = to write
Tissue inhomogeneities in Monte Carlo treatment planning for proton therapy L. Beaulieu 1, M. Bazalova 2,3, C. Furstoss 4, F. Verhaegen 2,5 (1) Centre.
Introduction The effect of air-cavities within the human body, for example in the head and neck regions, present possible sources of error when calculating.
Innovation/Impact: By designing a simulated human shaped (anthropomorphic) plastic phantom with targets, organs at risk (OAR) and heterogeneities, the.
At the position d max of maximum energy loss of radiation, the number of secondary ionizations products peaks which in turn maximizes the dose at that.
An Audit of breast radiotherapy reproducibility and an assessment of the role of breast volume on field placement accuracy. Heidi Probst PhD, Sarah Hielscher.
Dose Distribution and Scatter Analysis
Results The measured-to-predicted dose ratio criteria used by the RPC to credential institutions is , however for this work, a criteria of
Научно-практический центр протонной лучевой терапии и радиохирургии (Москва-Дубна) A SYSTEM FOR MEASUREMENT OF A THERAPEUTIC PROTON BEAM DOSE DISTRIBUTION.
Patient Plan Results: Table 3 shows the ratio of the Pinnacle TPS calculation to the DPM recalculation for the mean dose from selected regions of interest.
Evaluation of the Performance of the Fast Scanning Platform of an OCT System Malcolm Heard 1, Miguel Herrera 1, Geoffrey Ibbott 1 1 Department of Radiation.
Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.
MRI SIMULATION FOR CONFORMAL RADIATION THERAPY OF PROSTATE CANCER Pasquier D 1-3, Palos G 3, Castelain B 1, Lartigau E 1,2, Rousseau J 2,3 1 Department.
IMRT QA Plan Site 5%/3mm3%/3mm2%/2mm 0% noise1% noise2% noise0% noise1% noise2% noise0% noise1% noise2% noise HN
Seeram Chapter 9: Image Manipulation in CT
May 31, th PTCOG in Catania, Italy1 Treatment Planning for Broad-Beam 3D Irradiation Heavy-Ion Radiotherapy N. Kanematsu, M. Endo, and T. Kanai,
Application of a 2-D ionization chamber array for dose verification of dynamic IMRT with a micro-MLC Fujio ARAKI, PhD 1, S. TAJIRI 2, H. TOMINAGA 2, K.
The Radiological Physics Center’s Anthropomorphic Quality Assurance Phantom Program Carrie F. Amador, Nadia Hernandez, Andrea Molineu, Paola Alvarez, and.
Investigation of 3D Dosimetry for an Anthropomorphic Spine Phantom R. Grant 1,2, G. Ibbott 1, J. Yang 1, J. Adamovics 3, D Followill 1 (1)M.D. Anderson.
Physics of carbon ions and principles of beam scanning G. Kraft Biophysik, GSI, Darmstadt, Germany PTCOG43 Educational Satellite Meeting: Principles of.
Introduction The Radiological Physics Center (RPC) anthropomorphic quality assurance (QA) phantom program is one tool the RPC uses to remotely audit institutions.
Conclusions Despite being able to acquire successfully high resolution images of radiation dose, image quality is limited by hardware problems. Upgrading.
Correlation Evaluation of a Tumor Tracking System Using Multiple External Markers Hui Yan, Fang-Fang Yin, et al (Duke University Med. Ctr.)
Impact of Axial Compression for the mMR Simultaneous PET-MR Scanner Martin A Belzunce, Jim O’Doherty and Andrew J Reader King's College London, Division.
Assessment of radiotherapy set-up error for limb sarcoma using electronic portal imaging (EPI) Wendy Ella, Eleanor Gill, Anna Cassoni, Beatrice Seddon.
Chance Constrained Robust Energy Efficiency in Cognitive Radio Networks with Channel Uncertainty Yongjun Xu and Xiaohui Zhao College of Communication Engineering,
Wai-Hoi Wong 1, Hongdi Li 2, Yuxuan Zhang 1, Rocio Ramirez 1, Hossain Baghaei 1, Shaohui An 2, Chao Wang 2, Shitao Liu 2, Yun Dong 2 1 University of Texas.
Purpose N-isopropylacrylamide (NIPAM) polymer gel dosimeters were employed to verify the dose distribution of clinical intensity modulated radiation therapy.
Thickness of CZT detector 110 MeV140 MeV DETECTOR A (1 mm CZT + 5 mm CZT) DETECTOR B (1 mm CZT + 10 mm CZT) DETECTOR C (1 mm CZT + 15 mm CZT) A. Generation.
PET Scanner Calibration Using a Small Ga68/Ge68 Source
The Optimization of Reconstruction Method Reducing Partial Volume Effect in PET/CT 3D Image Acquisition Department of Nuclear Medicine, Samsung Medical.
References : [1] Hurkmans CW, et al Set-up verification using portal imaging; review of current clinical practice. Radiother. Oncol. 2001;58: [2]
A comparison between soft tissue and bone registration techniques for prostate radiotherapy Richard Small, Paul Bartley, Audrey Ogilvie, Nick West and.
3/15/2011Nigel Watson / NA62 Meeting. History Radial Ridge Cyclotron – since 2004 Scanditronix MC40 variable energy cyclotron maximum energies 40 MeV.
J Cho, G Ibbott, M Kerr, R Amos, and O Mawlawi
Methods & Materials (continued)
J Cho, G Ibbott, M Gillin, C Gonzalez-Lepera, U Titt and O Mawlawi
RHD-DoPET CNAO test beam result (may 2014)
Date of download: 10/11/2017 Copyright © ASME. All rights reserved.
Proton beam range verification using proton activated fiducials and off-site PET AAPM Best in Physics, Indianapolis, August 7, 2013 Cho J1, Ibbott G1,
Impact of moving target on measurement accuracy in 3D and 4D PET imaging—a phantom study  Yunfeng Cui, PhD, James Bowsher, PhD, Jing Cai, PhD, Fang-Fang.
Proton range verification with PET: 68Zn, Cu and polycarbonate activation SNMMI Young Investigator Symposium, Vancouver, June 9, 2013 Cho J1, Ibbott.
Reconstructions with TOF for in-beam PET
International Workshop on radiosensitization
Tuesday Case of the Day Physics History: A B MIP
Left Posterior Superior Right Anterior Inferior
A Comparative Study of Biological Effects of VHEE, Protons and other Radiotherapy Modalities Kristina Small University of Manchester, Christie NHS Foundation.
Template Matching Can Accurately Track Tumor Evaluation of Dose Calculation of RayStation Planning System in Heterogeneous Media Huijun Xu, Byongyong Yi,
A. Nisbet 1,2, A. Dimitriadis 1,2,3, A.L. Palmer 1,4, C.H. Clark 2,3
INFN Pisa tasks Development of a PET system
AAPM Annual Meeting, Anaheim, California July 13, 2015
Implementation of Object Spot Avoidance in Proton Pencil Beam Treatment on Whole Breast with Implant Metal Injector Peng Wang, PhD, DABR, Karla Leach,
Fig. 4. Percentage of passing rate between clinical and 544 plans.
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
PET-utilized proton range verification using 13N signals
Feasibility of using O-18 for PET proton range verification
L. A. den Otter. , R. M. Anakotta. , M. Dieters. , C. T. Muijs. , S
一种基于晶体间光分享原理的深度测量PET探测器
Improving Image Accuracy of ROI in CT Using Prior Image
Planning techniques of proton boost
Presentation transcript:

Characterization of proton-activated implantable markers for proton range verification using PET J. Cho1, G. Ibbott1, M. Kerr1, R. A. Amos2, F. Stingo1, and O. Mawlawi1 1 The University of Texas MD Anderson Cancer Center, Houston, TX, USA 2 University College London Hospitals NHS Foundation Trust, London, UK P207, PTCOG53: Shanghai, China. 2014 Background / Aim Conventional proton beam range verification using PET relies on tissue activation. This process however is affected by minimal activation near the end of the proton range, perfusion-driven activity washouts, and short half-lives of progeny radioisotopes, which requires an in-beam, in-room, or on-site PET scanner. While the installation of such a PET scanner can be financially and technically challenging for many proton centers, previous work (Cho et al Phys. Med. Biol. 58 7497-7512) showed that it was feasible to implant long-lived proton-activated fiducial markers for proton range verification using an off-site PET scanner. Here, we expand on that work by characterizing the relationships between marker volume, dose, and PET scan time in two tissue-like phantoms. The aim of this research was to determine the optimal marker volume to provide sufficient PET signal for several marker types, phantom materials, doses, and PET scan times. Results continues Results The visibility of activated markers increased in proportion to the marker volume, dose, and PET scan time for both phantoms. 60 and 120 min post-irradiation delays provided maximum marker SNR for balsa and beef phantoms, respectively. ± 2 mm depth variations were introduced for marker implantation from the maximum 68Zn and Cu activation depth (108 mm). 108 ± 2 mm (= 106, 110 mm) are the region of > 80% of maximum 68Zn activation. This variation in depths was adapted for practical consideration since it is very difficult to implant markers at exact depth in real clinical situation. The following figure shows no practical difference in visibility scores for 50 mm3 Cu markers embedded at two different depths. (a) (a) (b) (b) Methods & Materials Fig. 2: PET/CT fusion images of the balsa wood phantom in fig 1. (a) Beam’s eye view of the activated markers on the plane at depth 3 (108 mm/99%). (b) Lateral view on the plane of the 50 mm3 Cu markers. Two phantoms were made; one using low-density balsa wood (~ 0.1 g/cm3) as a lung substitute and a second using beef (~ 1.0 g/cm3) as a soft-tissue substitute. Markers made of two materials (Cu and 68Zn) and having three different volumes (10, 20, and 50 mm3) were embedded in each phantom. The phantoms and markers were irradiated with 160 MeV protons to four doses (1, 2, 3, and 5 Gy). The markers were located in the distal dose fall-off region, because a previous study showed the maximum activation occurred at this depth. After irradiation, the phantoms were moved to an off-site PET scanner and scanned in list-mode. Data were acquired with 20-, 30-, and 40-min scan times following several different delay times (30, 45, 60, 75, 90, 105, 120, 135, and 150 min) to investigate the maximum SNR. Reconstructed PET/CT images were then scored for marker visibility on a 5 point scale by 13 radiologists. We used a linear model, with marker visibility scores as the response variable and all other factors (marker type, marker volume, phantom material, dose, and PET scan time) as covariates to understand how marker volume affects the visibility score. (b) Fig. 5: Visibility score comparison of two 50 mm3 Cu markers embedded at two different depths and irradiated by 1 Gy. (a) Cu marker was embedded at a depth of 106 mm and the average visibility score was 4.2. (b) Cu marker was embedded at a depth of 110 mm and the average visibility score was 4.0. The marker volumes that provided a visibility score of 3 (moderately visible) were determined for both phantoms, several dose levels and all PET scan times. The phantom material was found to have very little influence on the marker volume required (average difference and standard deviation were 1.5 % and 1.4 %, respectively). (a)  Required marker volume (mm3) - Cu markers in low density balsa  PET scan time (min) Dose (Gy) 1 2 3 4 5 20 55 49 43 36 30 52 46 39 33 27 40 24 (b) Fig. 3: PET/CT fusion images of beef phantom of similar setup as fig 1. (a) Beam’s eye view on the plane at depth 2 (105 mm/100%). (b) Lateral view on the plane of the 50 mm3 Cu marker.  Required marker volume (mm3) - Cu markers in beef phantom  PET scan time (min) Dose (Gy) 1 2 3 4 5 20 55 48 42 36 30 52 45 39 33 27 40 49 24  Required marker volume (mm3) - 68Zn markers in low density balsa  PET scan time (min) Dose (Gy) 1 2 3 4 5 20 35 29 23 17 10 30 32 26 14 7 40 11 (a) (b) Tab. 1: The required volume of markers to provide a visibility score of 3. Conclusion (b) The visibility and marker volume information obtained in this study can be used as a guideline in planning preclinical studies using anthropomorphic phantoms or animals, with a long-term goal of optimizing such markers for clinical use. Fig. 4: Variation of average visibility scores with marker volume and dose for different marker materials, embedding phantom materials and PET scan times. The mesh grid is a linear interpolation of the measurement points (solid spheres). Fig. 1: (a) Proton irradiation setup for Cu and 68Zn markers embedded in a balsa wood phantom. (b) Locations of markers overlaid on the percentage depth dose (PDD) curve of the proton beam.